A longitudinal study by Sehr et al. investigated the effects of OSA treatment on neurodegenerative biomarkers, revealing that elevated serum NFL levels were associated with cognitive impairment in OSA patients. This evidence concerns the gene NEFL and obstructive sleep apnea syndrome.